Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-02-05
1989-01-31
Foelak, Morton
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514800, 530313, 530328, C07K 720, A61K 3743
Patent
active
048015776
ABSTRACT:
Synthetic nona- and decapeptide LHRH antagonist analogs are disclosed, having a sterically hindered guanidino-substituted arginyl or homoarginyl residue at position 8, with no arginyl substituent at position 6.
REFERENCES:
patent: 4215038 (1980-07-01), Rivier et al.
patent: 4341767 (1982-07-01), Nestor et al.
patent: 4419347 (1983-12-01), Nestor et al.
patent: 4481190 (1984-11-01), Nestor et al.
patent: 4569927 (1986-02-01), Rivier et al.
patent: 4581169 (1986-04-01), Nestor et al.
patent: 4667014 (1987-05-01), Nestor et al.
patent: 4690916 (1987-09-01), Nestor et al.
Karten et al., "In Vitro Histamine Release with LHRH Analogs", LHRH and its Analogs, Contraceptive and Therapeutic Applications, part 2 (1987).
Roeske et al., "LHRH Antagonists with Low Histamine Releasing Activity", LHRH and its Analogs, Contraceptive and Therapeutic Applications, part 2 (1987).
Nestor, Jr. John J.
Vickery Brian H.
Chan Christina
Foelak Morton
Krubiner Alan M.
Moran Tom M.
Syntex (U.S.A.) Inc.
LandOfFree
Nonapeptide and decapeptide analogs of LHRH useful as LHRH antag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonapeptide and decapeptide analogs of LHRH useful as LHRH antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonapeptide and decapeptide analogs of LHRH useful as LHRH antag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177507